当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

  

流通市值:2550.69亿  总市值:3077.15亿
流通股本:24.73亿   总股本:29.84亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金12,564,206,385.749,091,382,140.1834,327,532,724.9222,710,907,108.61
  收到的税费返还529,798,491.221,634,093,531.381,093,800,903.48812,228,117.9
  收到其他与经营活动有关的现金466,971,301.731,027,087,659.72690,144,986.47532,873,783.14
  经营活动现金流入小计13,560,976,178.6551,752,563,331.2836,111,478,614.8724,056,009,009.65
  购买商品、接受劳务支付的现金4,801,463,683.818,403,824,521.7913,228,850,010.168,617,574,553.83
  支付给职工以及为职工支付的现金3,549,166,099.9210,450,935,927.567,928,078,759.925,770,875,505.75
  支付的各项税费1,217,418,205.333,755,189,879.642,160,136,328.871,342,576,723.44
  支付其他与经营活动有关的现金397,117,863.071,939,451,380.291,381,578,848.45894,000,694.93
  经营活动现金流出小计9,965,165,852.1234,549,401,709.2824,698,643,947.416,625,027,477.95
  经营活动产生的现金流量净额3,595,810,326.5317,203,161,62211,412,834,667.477,430,981,531.7
二、投资活动产生的现金流量:
  收回投资收到的现金3,366,510,544.5121,007,291,673.4811,163,983,140.146,847,023,306.04
  取得投资收益收到的现金29,116,209.77482,697,536.68237,240,096.6258,168,449.95
  处置固定资产、无形资产和其他长期资产收回的现金净额24,688,122.375,118,927.49,761,249.999,375,735.07
  处置子公司及其他营业单位收到的现金净额398,053,880.942,902,727,868.21,343,881,409.161,255,520,822.86
  投资活动现金流入小计3,818,368,757.5224,467,836,005.7612,754,865,895.918,170,088,313.92
  购建固定资产、无形资产和其他长期资产支付的现金1,194,798,903.265,538,150,829.943,566,317,746.462,101,763,801.59
  投资支付的现金7,971,938,663.5520,874,795,084.78,783,584,477.764,258,782,879.04
  投资活动现金流出小计9,166,737,566.8126,412,945,914.6412,349,902,224.226,360,546,680.63
  投资活动产生的现金流量净额-5,348,368,809.29-1,945,109,908.88404,963,671.691,809,541,633.29
三、筹资活动产生的现金流量:
  吸收投资收到的现金-7,045,823,546.016,995,823,546.01-
  取得借款收到的现金3,377,302,944.5114,091,218,928.8111,575,750,138.887,677,208,916.66
  筹资活动现金流入小计3,377,302,944.5121,137,042,474.8218,571,573,684.897,677,208,916.66
  偿还债务支付的现金3,400,300,00010,528,620,797.528,718,797,498.615,222,657,871.55
  分配股利、利润或偿付利息支付的现金16,953,610.044,992,100,926.544,966,801,138.593,915,938,314.7
  其中:子公司支付给少数股东的股利、利润-23,518,29023,518,29021,980,664
  支付其他与筹资活动有关的现金35,028,816.844,492,779,705.34,463,317,745.013,467,940,039.82
  筹资活动现金流出小计3,452,282,426.8820,013,501,429.3618,148,916,382.2112,606,536,226.07
  筹资活动产生的现金流量净额-74,979,482.371,123,541,045.46422,657,302.68-4,929,327,309.41
四、汇率变动对现金及现金等价物的影响-198,774,624.87-370,473,427.27-209,209,966.1-203,423,250.66
五、现金及现金等价物净增加额-2,026,312,59016,011,119,331.3112,031,245,675.744,107,772,604.92
  加:期初现金及现金等价物余额29,455,830,548.9513,444,711,217.6413,444,711,217.6413,444,711,217.64
  期末现金及现金等价物余额27,429,517,958.9529,455,830,548.9525,475,956,893.3817,552,483,822.56
补充资料:
  净利润-19,333,065,892.26-8,660,348,120.54
  资产减值准备-541,555,966.37-321,420,123.36
  固定资产和投资性房地产折旧-3,164,557,339.38-1,527,089,686.4
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,164,557,339.38-1,527,089,686.4
  无形资产摊销-132,413,984.1-68,534,477.74
  长期待摊费用摊销-89,610,245.16-49,264,471.95
  处置固定资产、无形资产和其他长期资产的损失-58,067,020.13-12,844,822.74
  固定资产报废损失-7,094,067.73-2,485,850.82
  公允价值变动损失-137,097,911.32-182,183,014.07
  财务费用-1,073,373,133.94-522,731,890.77
  投资损失--8,588,017,064.9--3,669,213,003.27
  递延所得税--197,904,753.64--137,723,370.66
  其中:递延所得税资产减少--115,912,084.53--69,001,444.91
    递延所得税负债增加--81,992,669.11--68,721,925.75
  存货的减少--3,662,118,123.51--1,800,680,510.95
  经营性应收项目的减少--229,618,572.96-657,038,345.86
  经营性应付项目的增加-3,797,761,790.71-515,774,644.13
  其他-801,757,310.91-212,203,859.97
  现金的期末余额-29,455,830,548.95-17,552,483,822.56
  减:现金的期初余额-13,444,711,217.64-13,444,711,217.64
  现金及现金等价物的净增加额-16,011,119,331.31-4,107,772,604.92
公告日期2026-04-282026-03-242025-10-272025-07-29
审计意见(境内)标准无保留意见
TOP↑